drugset / Trial / NCT00327717

Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures

NCT00327717

Phase 3 Completed 240 enrolled Eisai Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The objectives of this trial are to evaluate the safety and efficacy of Zonisamide as adjunctive therapy in medically refractory patients receiving other antiepileptic drugs (AEDs).

Timeline

Start
2006-09
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Zonisamide Other / unclassified 300 mg
Subject Zonisamide Other / unclassified 400 mg

Indications